MMXPR3AADC<\#176>m<\#168>' <\#198><\#174><\#255><\#252><\#166>.<\#253><\#245><\#221>.<\#255><\#128>H<\#128>$<\#128><\#128> $<\#136>_<\#174><\#208><\#254>$$ <\#154><\#174><\#255> v<\#136><\#251><\#146><\#136>$<\#253>w~<\#252><\#240><\#174><\#191>Y<\#154><\#153><\#154><\#153><\#154>Y<\#154><\#153><\#154><\#153><\#154><\#153><\#154><\#153><\#154><\#192><\#192>@s<\#251><\#254><\#236>UU<\#243>3<\#240>) <\#220><\#228><\#128><\#176><\#131><\#131><\#131><\#131><\#131>xHH<\#183><\#255><\#247><\#255><\#247><\#191>"<\#248>(HH<\#216>(d' ]<\#224><\#165><\#144><\#255><\#253><\#255><\#253>9x<\#192><\#255><\#255>&aE,<<\#9><\#216><\#208><\#255><\#252><<\#255><\#252><K<\#255><\#252><\#255><\#255><\#255><\#252><<\#255><\#252><-<\#255><\#252><<\#255><\#252><K<\#255><\#252><<\#255><\#252><-Splash G620-DocuColor 12 <\#243>ACaslon-Grid-RegACaslon-Grid-Reg2ACaslon RegularACaslon-Regular3ACaslon ItalicACaslon-Italic4 ACaslon Bold ACaslon-Bold:vCB Helvetica Condensed BoldHelvetica-Condensed-Bold:|CL Helvetica Condensed LightHelvetica-Condensed-Light<\#243>2(ACaslon-SemiboldACaslon-ItalicACaslon-SemiboldItalic3LACaslon-SemiboldItalic4nACaslon-BoldItalic:v<\#140>Helvetica-Condensed-BoldObl:|<\#197>Helvetica-Condensed-LightObl<\#212>CLST<\#144>X<\#156>P<\#212>d<\#148>0 $<\#176>0<\#188> <\#200>T `<\#236><\#248> , Th<\#128>x| <\#132> (<\#180> <\#192> <\#204>Xd t 4 8<\#196><\#208> <\#212><\#9>`<\#9>l <\#9>p<\#9><\#252>  <\#255><\#255><\#255><\#248> <\#152> <\#164> <\#168> 4 D H <\#212> <\#228> <\#232> t <\#132> <\#136>  $ ( <\#180> <\#196> <\#200> Td<\#140><\#180><\#220>,T|<\#164><\#204><\#244> D<\#208> <\#220><\#240> ,X<\#132><\#128><\#172><\#176><\#192><\#232> $L<\#128>\<\#128>`~ "%(+.147:H<\#240>WhiteQRGB<\#128><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#254><\#128><\#128><<\#240>QRGB###<\#240>Black:QCMK<\#128><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#128><\#128><\#240>QCMK!!!#H NMPnCo<\#9>QCMK  <\#255><\#255><\#255><\#255><\#220>}<\#151>}<\#181>=<\#240>NAM=5455<\#240>PANTONE 5455 CV<\#240>QCMKF`PIXd#!<\#240>QCMK?|[!!@[IQRGBI<\#143>5R'b<\#255><\#252><\#255><\#255><\#247><\#240>QCMKJAbEDF!!W<\#240><\#240>CyanQCMK<\#128><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#172><\#200>m<\#166>g/B<\#240>QCMK#!!!<\#240>MagentaQCMK<\#128><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#128><\#212><\#203>r<\#130>D<\#240>QCMK!#!!<\#240>YellowQCMK<\#128><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#246><\#158>c%<\#220>iG<\#240>QCMK!!#!<\#240>RegistrationHQRGB<\#128> <\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#128><\#128>F<\#240>QRGB!!!QRGB~<\#240>"QCMK <\#9>D<\#255><\#255><\#255><\#255><\#172><\#200>m<\#166>g/<\#240>QCMK#!!!<\#240>%!QCMK# D<\#255><\#255><\#255><\#255><\#128><\#212><\#203>r<\#130><\#240>QCMK!#!!<\#240>"($QCMK& D<\#255><\#255><\#255><\#255><\#246><\#158>c%<\#220>i<\#240>QCMK!!#!<\#240>%+'QCMK) D<\#255><\#255><\#255><\#255><\#128><\#128><\#240>QCMK!!!#<\#240>(.*PnHx, D<\#255><\#255><\#255><\#255><\#172><\#200>m<\#166>g/<\#240>PnHx#!!!!!<\#240>+1-PnHx/D<\#255><\#255><\#255><\#255><\#128><\#212><\#203>r<\#130><\#240>PnHx!#!!!!<\#240>.40PnHx2D<\#255><\#255><\#255><\#255><\#246><\#158>c%<\#220>i<\#240>PnHx!!#!!!<\#240>173PnHx5D<\#255><\#255><\#255><\#255><\#128><\#128><\#240>PnHx!!!#!!<\#240>4:6PnHx8D<\#255><\#255><\#255><\#255><\#143><\#188><\#192><\#192><\#216><\#240>PnHx!!!!#!<\#240>79PnHx;D<\#255><\#255><\#255><\#255><\#191><\#176>W<\#218><\#157><\#148><\#240>PnHx!!!!!#QRGB~<\#255><\#255><\#255><\#255><\#255><\#255>QRGB~<\#196><\#208>X<\#211><\#148>QRGBI<\#179>*<\#204><\#232><\#227><\#133>QRGB~S<\#176><\#163>xQRGBx<\#148>w<\#232>xWQRGB<\#255><\#255>QRGB~<\#229><\#160>[<\#198><\#135>QRGB<\#255><\#255>QRGB~<\#239><\#255>&QRGB<\#255><\#255>QRGB~QRGB~<\#255><\#255><\#255><\#255>JNMPnCoIQCMKV<\#9><\#255><\#255><\#255><\#255>j<\#129><\#128>OY?<\#240>NAM=660<\#240>PANTONE 660 CVQRGBD 3.7<\#138>=<\#255><\#252>o<\#255><\#255><\#255>QRKITRPDNHNQRKITRPDLHMMQRGB7<\#229><\#173><\#221>e<\#168>~<\#240>QCMK#J`P!?|[QRGByx<\#181><\#188><\#164>QRGBy2<\#215><\#132><\#204><\#240>QCMK@og!?|[?|[QRGBy<\#203><\#171><\#218><\#160><\#215><\#195><\#240>QCMKMbsHeX!!X<\#240>QCMKMbsHeX!!XXMbsHeX!!X<\#240>QCMKMbsHeX!!X<\#132><\#204><\#240>QCMK@og!?|[?|[QRGBy<\#203><\#171><\#218><\#160><\#215><\#195><\#240>QCMKMbsHeX!!XXMbsHeX!!XRPLCX. )(54oG&43253.2*cG&325&+.4*uG&325&+.43uG" +"$3!2+eG" +. ")$"oG%+. &3.) G%+. &3.()G%4"51&)$"G$3&) 2+&5 G*).4$.")3G77(4.3.()G5 &).="54 G5 &).=.) G&5&*"3"54 G&5&7/5&4"wG&562"3.) eG&35.(3.4* G")3/(24"4VG"5.(#.$&+G"5(?.#.) mG"57"35&3"oG"54.43")3eG/.+&3"+.$^G/(3( ").$nG/(3( 5&7/oG/(3(*25&+mG.$&5"462"wG.++(0$&4"cG.+(3/(24"G+&)"3(.#4_G+&>/(24"4VG()3.!.$&+aG((5/(24"4VG(0"5/(24"oG5"#.47(4"cG5"4%>3"5>S<\#199>5"4277(4"cG5"1").")3cG5"1")3.()cG5"1")3.1"cG5(!"44.) eG5(!"44(54cG5( ").3(5aG5(-"$3.+"cG5(-"$3.) eG5(+($23(5aG5(*.44(5>SG5(*2+ &3"SG5(7& &)#&^G2 )&$.(24oG25$/&4.) eG62&3.$4UG62&3.) UG62&5&)3.)"SG&$"/(54"4VG&$,"3""54SG&3.()&++>G&1")(24+>nG"$.75($&+ G"$( ).="#oG"$(*7")4"oG"$>$+&%+"G"/"&54.) G".*%254"4G"(5 &).="G"7")3&)$"G"7/5&4.) G"75"4")34oG"4.43&)$"G"47()#")3G"47()#.) G"42+3&)34G"1($&3.()sG(.43"5"54MG(.43"5(24MG(2)#/(24"OG&+"4$+"5,OG&+"40(*&)NG&3>5.&4.4G XNormal``<\#255><\#255><\#255><\#255><\#255><\#225> *-main page head<\#255><\#254>` <\#255><\#255><\#243> ft-tabtext copy<\#255><\#254> 3<\#224> `<\#163><\#215><\#128>p<\#153><\#154><\#255><\#255><\#243> <\#255><\#254>ft----------------------------<\#255><\#254> $<\#134>  `<\#163><\#215><\#128>p<\#153><\#154><\#255><\#255><\#243><\#128><\#255><\#254>ft-tabtext w/2 pt rule bel copys tabletextext<\#255><\#254> &<\#151><\#144>  <\#160>`<\#163><\#215> <\#128><\#255><\#255><\#243> <\#255><\#254>ft-tabtext w/1 pt rule bel copy<\#255><\#254> $<\#144><\#132>  <\#160>`<\#163><\#215> <\#128><\#255><\#255><\#243> <\#255><\#254>+ft-dateline w/.375 rule bel, for 1 & 2 line copy<\#255><\#254> $<\#138>  <\#255><\#252><\#160> <\#128><\#255><\#255>:v /ft-dateline w/12 pt white rule abv, 1 of 2 line copy<\#255><\#254> (v<\#128> <\#255><\#252><\#160> <\#128><\#255><\#255>:v  ft-footnotestes<\#9><\#255><\#254> 2T `<\#163><\#215><\#128>p<\#153><\#154><\#255><\#255>3<\#9><\#255><\#254>*-Section Headt <\#255><\#254>`0<\#255><\#255>:|0 *-contentsSheet <\#255><\#254> $<\#140>,`<\#255><\#255>:| *-Dollar amounts... <\#255><\#254>` <\#255><\#255><\#243><\#9>-ft-dateline w/.375 rule above, for 1 & 2 lineopy<\#255><\#254> &<\#163>4  `  <\#128><\#255><\#255>:v ft-dateline w/rule above<\#255><\#254> ))<\#248>    <\#128><\#255><\#255>:v (. . ) k) <\#197>) (. . ) k) <\#197>) . ! . ) <\#159>) <\#210>) ,) k) <\#197>) (. . ) k) <\#197>) (. . ) k) <\#197>) (. . ) k) <\#197>) 8) ) ,) V) <\#128>) <\#203>) <\#245>) (. . ) k) -<\#197>) <\#140>Normald<\#243> P`<\#255><\#255><\#217><\#154><\#154><\#128> =Standard.<\#255><\#255><\#151> <\#255><\#255><\#227><\#215> grid-quark<\#255><\#255><\#151> <\#255><\#255><\#227><\#215>grid-quark (no hyphens) <\#212><\#255><\#255><\#255><\#209> Solid<\#153><\#154>ffDotted<\#192>@Dotted 2<\#139><\#163>.<\#140>F.<\#140>Dash Dot All DotsUSUSUSDouble*<\#173>US<\#128> Thin-Thick<\#128>US*<\#173> Thick-Thin 5SUS5S Thin-Thick-ThinI$$<\#149>$<\#149>$<\#149>I$<\#9>Thick-Thin-Thick*<\#173>@*<\#173>@*<\#173> Triple<\#220> $<\#146><\#148># $<\#137>h$ $<\#136>  $<\#136>:(! 5<\#128>" (vX& &<\#152> (vl $<\#137><\#236> $<\#137>p' $<\#137><\#196>( $<\#138>h) 8<\#156>+ 5<\#152> $<\#139><\#252> &<\#167><\#164>1 $<\#137><\#232>3 $<\#137><\#172>5 )44 (v86 $<\#136>L8 <\#215><\#213>T<\#255><\#255> (u<\#252> (v$ $<\#136><\#136> $<\#135><\#248> &<\#165>,<\#216>@;<\#153> <\#216><\#9>@<<\#153> <\#216> @<\#153>= <\#216>@<\#153>$ ><\#216>@<\#153>$ ?<\#216>@<\#153>$ <\#216>@ @<\#153> <\#128>A@<\#153><\#153><\#255><\#255><\#255><\#190><\#9>@<\#153><\#153> @<\#153>D<\#153>@<\#153>$E<\#153>@<\#153>$F<\#153>@<\#153>$G<\#153> @<\#153>H<\#153><\#148>@<\#153>I<\#148>@<\#153><\#148>@J<\#153><\#148>@<\#153><\#216>K<\#192><\#153> <\#216>L<\#192><\#153> <\#216><\#192>M<\#153> <\#216><\#192><\#153>N  <\#153>@<\#156>@<\#153>O<\#156>@<\#153><\#156>@P<\#153><\#148>@<\#153> <\#255><\#255><\#255><\#175> <\#255><\#254><\#243> <\#255><\#241><\#255><\#254><\#255><\#254><\#243><\#255><\#146><\#255><\#254><\#243><\#128><\#255><\#254><\#255><\#254>2 <\#204><\#204><\#255><\#254> <\#255><\#254>3 <\#255><\#254><\#255><\#254><\#243><\#255><\#249><\#255><\#252><\#255><\#254><\#243><\#255><\#248><\#255><\#252><\#255><\#254><\#243><\#255><\#226><\#255><\#252><\#255><\#254>3<\#9><\#255><\#254><\#255><\#254><\#243><\#255><\#236><\#255><\#254>3 <\#255><\#236><\#255><\#254><\#255><\#254><\#243> <\#255><\#254><\#243><\#9><\#255><\#254><\#255><\#254>2 <\#255><\#254>2 <\#142><\#255><\#254>2 <\#255><\#254><\#255><\#254>4 <\#204><\#204><\#255><\#254> <\#255><\#254><\#243> <\#255><\#254><\#255><\#254><\#243> <\#204><\#204><\#255><\#254><\#255><\#254><\#243> <\#9><\#255><\#254>3<\#9><\#255><\#254><\#255><\#254>:v <\#204><\#204><\#255><\#254>:v <\#255><\#254><\#140><\#255><\#254><\#243> <\#255><\#254><\#255><\#254>3<\#128><\#9><\#255><\#254><\#255><\#254><\#243><\#255><\#251><\#255><\#254>2 <\#255><\#254>3 <\#255><\#241><\#255><\#254> <\#255><\#254>:v {<\#255><\#254>4 <\#255><\#254><\#255><\#254><\#243><\#255><\#251><\#255><\#252>:v <\#243> <\#255><\#254><\#243><\#255><\#241><\#255><\#252>3<\#255><\#255><\#208><\#255><\#254><\#243><\#255><\#246><\#255><\#252>3<\#255><\#254><\#243><\#255><\#254><\#255><\#254><\#243><\#255><\#241><\#255><\#254><\#255><\#255>L<\#204><\#255><\#254><\#243><\#255><\#253><\#255><\#252><\#255><\#254><\#243><\#9><\#255><\#254><\#243>  <\#255><\#254><\#243><\#255><\#254><\#243><\#255><\#252><\#255><\#254>3 <\#255><\#226><\#255><\#254><\#255><\#254>:v <\#255><\#254><\#243> <\#255><\#236><\#255><\#254> <\#255><\#254>:v ]<\#192> )*<\#136> $<\#137><\#168> $<\#140><\#128>  (v<\#208><\#9> $<\#138><\#172>  (w<\#156> (vP<\#9> )#<\#228> &<\#152><\#164> $<\#137><\#220> (wl (wt $u<\#136> (w<\#220> (vL ))<\#140> . ) <\#159>) <\#210>) . <\#178>.^ <\#204>@. . . ;"<\#143>) k. <\#150><\#252><\#172>) <\#197>. <\#239><\#159>}) P) x) <\#202>) ) <\#184>)  ) \( <\#174>) ) R) <\#164>(. <\#180>) <\#212>{) D\)) <\#230>) '<\#128>0. . ) k. <\#147><\#235><\#199>) <\#197>) _X. ) x) <\#202>) ) <\#184>)  ) \) <\#174>) ) R) <\#164> . ) x) <\#202>) H) ) <\#198>) ) >. V<\#159>}) <\#134>) <\#212>. <\#236><\#159>}) @. . . 9gm. :u`<\#195>) k. <\#147><\#235><\#199>) <\#197>) 8) ) <\#198>) ) >) <\#134>) <\#212>) H) ) <\#198>) ) >. V ) <\#134>) <\#212>. <\#237><\#252><\#172>) (. . ) k) <\#197>) . ) k) <\#197>a) 8) ) <\#198>) ) >) <\#134>) <\#212><\#213> <\#244>`<\#255><\#255>`<\#255><\#255><\#255><\#158>  <\#160>`<\#163><\#215>;"<\#143> @`p  <\#160>`<\#163><\#215><\#147><\#128> <\#128>  <\#160>`<\#163><\#215><\#147><\#128> <\#128> <\#128>`<\#163><\#215><\#128><\#153><\#154> ` <\#255><\#255>` <\#255><\#255> <\#255><\#252><\#160> <\#128>  <\#160>`<\#163><\#215><\#171>~<\#250> @<\#9>  <\#160>`<\#163><\#215>9<\#128> <\#128> `<\#163><\#215><\#128>p<\#153><\#154>p  <\#224>`<\#163><\#215><\#224><\#159>} @<\#9>  <\#255><\#252><\#160> <\#128>  <\#160>`<\#163><\#215>9<\#128> <\#128> `<\#163><\#215><\#128>p<\#153><\#154>@  <\#160>`<\#163><\#215><\#171>~<\#250> @p   `<\#163><\#215><\#147><\#128> <\#128>  <\#255><\#252><\#160> <\#128> `<\#163><\#215><\#128>p<\#153><\#154>@ <\#128>`<\#163><\#215><\#128>p<\#153><\#154> <\#255><\#252><\#160> <\#128>  <\#128>`  <\#128>    <\#128> `<\#163><\#215><\#128>;"<\#143><\#153><\#154>@  <\#224>`<\#163><\#215><\#224><\#159>} @<\#9>   `<\#163><\#215><\#147><\#128> <\#128>  <\#160>`<\#163><\#215>;"<\#143> @ @`<\#163><\#215><\#128>p<\#153><\#154>@<\#9>   `<\#163><\#215><\#147><\#128> <\#128>  <\#224>`<\#163><\#215><\#171>~<\#250> @<\#9><\#9> <\#9>`<\#163><\#215><\#128>p<\#153><\#154>  <\#160>`<\#163><\#215><\#171>~<\#250> @ <\#9><\#132> `<\#163><\#215><\#128>p<\#153><\#154> `<\#163><\#215><\#128>p<\#153><\#154>@  <\#160>`<\#163><\#215>;"<\#143> @ <\#255><\#252><\#160> <\#128> <\#255><\#252><\#160> <\#128><\#9>p  <\#160>`<\#163><\#215>;"<\#143> @<\#9>  `<\#163><\#215><\#128>p<\#153><\#154> `<\#163><\#215><\#128>p<\#153><\#154>@<\#9> `<\#163><\#215><\#128>p<\#153><\#154> <\#160>`<\#163><\#215>-<\#128> <\#128>  `<\#163><\#215><\#128>p<\#153><\#154> <\#255><\#252><\#160> <\#128> <\#128><\#128>`<\#163><\#215><\#128>p<\#153><\#154>  @<\#255><\#255><\#255><\#255><\#139>Ox<\#153><\#253><\#165><\#255><\#140><\#252><\#143><\#239><\#144><\#149><\#147><\#151><\#159><\#248><\#160><\#161><\#204><\#162><\#254><\#163><\#249><\#145><\#215><\#174><\#214><\#144>-  /#  i(<\#9><\#148><\#9><\#252><\#160> @  <\#9>  @  <\#160>`<\#163><\#215>;"<\#143> @  @ <\#128>p<\#153><\#154>@<\#9> `<\#163><\#215><\#128>p<\#153><\#154>    <\#128>  <\#160>`<\#163><\#215>9<\#128> <\#128>  <\#255><\#252><\#160> <\#128><\#9>  <\#128><\#160>`<\#163><\#215><\#171>~<\#250> @ ` <\#255><\#255> <\#160>`<\#163><\#215><\#171>~<\#250> @<\#9> <\#128>`<\#163><\#215><\#128>p<\#153><\#154>@ <\#160>`<\#163><\#215>-<\#128> <\#128> `<\#163><\#215><\#128>p<\#153><\#154>@ `<\#163><\#215><\#128> <\#153><\#154>@p  <\#160>`<\#163><\#215>;"<\#143> @<\#9><\#132> `<\#163><\#215><\#128>p<\#153><\#154>p  <\#160>`<\#163><\#215>9<\#128> <\#128>p  <\#160>`<\#163><\#215>;"<\#143> @  <\#255><\#252><\#160> <\#128><\#9>  @<\#255><\#252><\#160> @   <\#255><\#252><\#160> <\#128>8QRkjDefault <\#249><\#192>$APBv,<\#247><\#219>0<\#228><\#254>I 3}<\#174>XPDF<\#9>16931 FIN<\#255><\#255><\#255><\#130>H<\#160>H<\#160>,1<\#192><\#128>Y<\#154>Acrobat DistillerB,XABL<\#255><\#160><\#136>APB<\#196><\#200> <\#128>T2<\#128><\#128><\#128>3&ACaslon Italic<\#192> <\#222>z<\#144><\#196>]b<\#192>,B<\#160>,<\#240>&!NE`: ft-10 pt Italic runins]b<\#192>*~<\#255><\#255><\#255><\#207>+<\#244> Black&<\#171>,?<\#128> <\#239>D&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@*~Z<\#228>0v<\#220>ZD&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>3# ACaslon Bold<\#192> <\#192> <\#222><\#188> <\#196>]b<\#192>,B<\#160>,<\#240>&!NE`: ft-current yearx]b<\#192>&r<\#255><\#255><\#255><\#207>+<\#244> PANTONE 661 CV<\#239>D&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@&rZ<\#228>0v<\#220>ZD&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>:vHelvetica CondensedBold<\#143><\#240>^<\#191>`<\#204>OT@<\#144>-`<\#255><\#207>+<\#244> ft-current year date0@<\#144>0^<\#191>`<\#255><\#209><\#152> .5dOT <\#136>Oa0<<\#128>1<\#206>\PANTONE 661 CV^<\#196>< mB<\#192><\#196> <\#215>@<\#128><\#255><\#255><\#255><\#255><\#255><\#255>E<\#200> <\#128><\#255><\#254><\#128>3'ACaslon Regular<\#192> <\#222>`<\#196>]b<\#192>,B<\#160>,<\#240>&!NE`: ft-remaining years]b<\#192>.|<\#255><\#255><\#255><\#207>+<\#244> Black&<\#171>,?<\#128> <\#239>D&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@.|Z<\#228>0v<\#220>ZD&<\#170><\#144>DH0BKG0listreco<\#150>posnTEXTACaslon-Grid-RegkindTEXTPS PairfounTEXT Adobe Systemsofszlong<\#239><\#187>pclstypefspcreco<\#146>posnTEXT ACaslon-BoldkindTEXTPS PairfounTEXT Adobe SystemsXpclstypefspcreco<\#150>posnTEXTACaslon-RegularkindTEXTPS PairfounTEXT Adobe Systemspclstypefspcreco<\#148>posnTEXTACaslon-ItalickindTEXTPS PairfounTEXT Adobe Systemsofszlong<\#201><\#204>pclstypefspcreco<\#158>posnTEXTHelvetica-Condensed-BoldkindTEXTPS PairdfounTEXT Adobe Systems6ofszlongzpclstypefspc<\#212>XCL2CMSD<\#212><\#212>p0<\#156>0<\#172>0<\#188><\#204>0l0|<\#140><\#176>0<\#212>0<\#228> <\#244>   0D|0<\#180>0<\#196><\#144> QGRYQRGB<\#9>QHSB QLAB QXYZQCMKPnHxPnCoToy0Dic0Tru0Foc0PnPrPnPSPnUnPnHUPnHCApple 13" RGB StandardApple 13" RGB Standardint#0int#0int#1int#1+Light GCR 280 UCR CMYK US Negative Proofing+Light GCR 280 UCR CMYK US Negative ProofingD<\#255><\#255>$<\#136>3 $<\#139>4<\#255><\#255><\#255>H<\#128>H<\#128>$<\#128><\#128> <\#255><\#255><\#174><\#255><\#132>$<\#136>3<\#234>.17<\#9>1.15<\#9>1.08 Dividends per common share<\#9>0.9200<\#9>0.9050<\#9>0.8700<\#9>0.8300<\#9>0.7825<\#9>0.7550<\#9>0.7350<\#9>0.7150<\#9>0.6650<\#9>0.5938 Year-End Financial Position Current assets(1)<\#9>$10,180,811<\#9>$12,384,778<\#9>$10,698,188<\#9>$10,025,512<\#9>$10,310,256<\#9>$11,084,841<\#9>$11,321,682<\#9>$4,807,684<\#9><\#9><\#9>$<\#9>W<\#170>W<\#160>!+#+#++++#'+*(6!6<\#128>+<\#255><\#255><\#249><\#159><\#147>n<\#128><\#147>n<\#132><\#9><\#184><\#210>5<\#173>5)$"35lstypefspcD<\#255><\#255>$<\#136>3 v<\#168><\#255><\#255><\#255>H<\#128>H<\#128>$<\#128><\#128> ?<\#240><\#132>$<\#136>3 v<\#152><\#255><\#255><\#255><\#128>H<\#128>$<\#128><\#128> $4,552,077<\#9>$4,119,057 Current liabilities(1)(5)<\#9>9,742,059<\#9>6,480,383<\#9>3,478,119<\#9>3,476,322<\#9>3,584,256<\#9>3,929,940<\#9>4,291,452<\#9>1,584,411<\#9>1,492,717<\#9>1,270,135 Ratio of current assets to current liabilities(1)(5)<\#9>1.05<\#9>1.91<\#9>3.08<\#9>2.88<\#9>2.88<\#9>2.82<\#9>2.64<\#9>3.0.88<\#9>2.82<\#9>1.69<\#9>3.03<\#9>3.05<\#9>3.24 Total assets(1)<\#9>21,092,466<\#9>23,123,756<\#9>20,224,231<\#9>19,851,517<\#9>19,924,666<\#9>20,721,093<\#9>21,328,267<\#9>7,687,353<\#9>7,141,405<\#9>5,938,797 Long-term debt(1)<\#9>2,394,790<\#9>3,606,423<\#9>3,839,402<\#9>5,007,610<\#9>6,010,297<\#9>7,806,717<\#9>9,972,444<\#9>859,278<\#9>601,934<\#9>104,710 Average sarding the use of the diet drugs Redux or Pondimin. The initial litigation charge of $4,750,000 was recordedin the 1999 third quarter. As a result of these litigation charges, current liabilities have increased subbbbbtially in 2000 and 1999 compared with <\#156>h<\#164><\#197><\#236><\#198><\#225><\#250><\#227><\#174><\#181><\#248><\#185><\#203><\#232><\#233><\#253><\#237><\#228><\#214><\#202><\#215><\#255><\#244><\#135><\#249><\#246><\#200>- /* <\#160>  4  <\#217> Weighted average common shares outstanding used for <\#9>diluted earnings per share calculation (in thousands)(3)<\#9>1,306,474<\#9>1,308,876<\#9>1,336,641<\#9>1,312,975<\#9>1,287,790<\#9>1,250,902<\#9>1,234,100<\#9>1,252,990<\#9>1,267,240<\#9>1,273,390 Employment Data(1) Number of employees at ye \<<\#9>/?/ i Z.-  ` T<\#150>tockholders<\#213> equity(5)<\#9>4,516,420<\#9>7,914,772<\#9>8,895,024<\#9>7,568,672<\#9>6,252,545<\#9>4,898,550<\#9>4,065,295<\#9>3,719,539<\#9>3,431,568<\#9>2,987,885 Stockholders<\#209>Outstanding Shares Number of common stockholders<\#9>58,355<\#9>62,482<\#9>65,124<\#9>64,313<\#9>67,545<\#9>68,763<\#9>71,223<\#9>72,664<\#9>73,064<\#9>71,209 Z/ /?k Z/? i)<\#9>HR: <\#167>ar end<\#9>48,036<\#9>46,815<\#9>47,446<\#9>54,921<\#9>54,194<\#9>58,957<\#9>70,300<\#9>51,399<\#9>50,653<\#9>47,938 Wages and salaries<\#9>$<\#202>2,264,258<\#9>$<\#202>2,032,431<\#9>$<\#202>2,175,517<\#9>$<\#202>2,428,518<\#9>$<\#202>2,439,604<\#9>$<\#202>2,512,418<\#9>$<\#202>1,811,402<\#9>$1,654,984<\#9>$1,575,615<\#9>$1,388,397 Bene<\#222>ts (including social security taxes)<\#9>6<\#177>H<\#154><\#214><\#188><\#193><\#192><\#205><\#194><\#208><\#201><\#255><\#191><\#207><\#202><\#176><\#206><\#192>0 -/  <\#9>*      <\#155>Years Ended December 31,<\#9>2000<\#9>1999<\#9>1998<\#9>1997<\#9>1996<\#9>1995<\#9>1994(4)<\#9>1993<\#9>1992<\#9>1991 Summary of Net Revenue and Earnings Net revenue(1)<\#9>$13,262,754<\#9>$11,881,196<\#9>$11,268,570<\#9>$12,076,621<\#9>$12,099,428<\#9>$11,466,287<\#9>$<\#202>8,882,952<\#9>$8,304,851<\#9>$7,873,687<\#9>$7,079,443 Income December 31,<\#9><\#9>2000<\#9>1999 Assets Cash and cash equivalents <\#9><\#9>$<\#202>2,644,306<\#9>$<\#202>1,892,715 Marketable securities <\#9><\#9>341,031<\#9>520,587 Accounts receivable less allowances (2000<\#209>$144,150 and 1999<\#209>$141,759)<\#9><\#9>2,740,272<\#9>2,38999<\#9>1,607,960 Net assets<\#209>discontinued bus % /    %<\#9>         <\#158>6<\#180>6"4$)6&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@0nZ<\#228>0v<\#220>ZD&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>3'ACaslon Regular<\#192> <\#222>`<\#196>]b<\#192>,B<\#160>,<\#240>&!NE`: ft-remaining years]b<\#192>.|<\#255><\#255>5<\#230>5)$"35v<\#220>ZD&<\#170><\#144>DHD<\#255><\#255>$<\#136>3 <\#155>V <\#255><\#255><\#255>H<\#128>H<\#128>$<\#128><\#128> \x<\#132>$<\#136>3 <\#223>a<<\#255><\#255><\#255><\#128>H<\#128>$<\#128><\#128>   H   &     /   <\#9>  #<\#9><\#166>02,816<\#9>593,222<\#9>577,930<\#9>619,528<\#9>614,179<\#9>641,169<\#9>439,572<\#9>396,045<\#9>367,899<\#9>300,810 (1)<\#9>As a result of the sale of the Cyanamid Agricultural Products business on June 30, 2000, amounts for the years 1994 through 1999 were restated to reflect this businns business as a discontinued operation. Beginning in 1994, current assets include the net assets of the discontinued business held for sale related to the Cyanamid Agricultural Products business. (2)<\#9>See <\#210>Management<\#213>s Discussion and Analysis of Financial Condition and Results of Operations<\#211> for amounts related to gains on sales of business and Immunex common stock, termination fee, litigation charges, goodwill impairment and special charges for the years ended DDDpairment and special charges for the years ended December 31, 2000, 1999 and 1998. (3)<\#9>The weighted average common shares outstanding for diluted loss per share for 2000 and 1999 did not include common share equivalents, as the effect would have been antidilutive. (4)<\#9>The 1994 information reflects theee acquisition of American Cyanamid Company for the one-month period ended December 31, 1994. (5)<\#9>In the 2000 fourth quarter, the Company recorded an additional litigation charge of $7,500,000 related to the litigation brought against the Company regggy regYears Ended December 31,<\#9>2000<\#9>1999<\#9>1998 Operating Activities Income (loss) from continuing operations <\#9>$<\#9>(901,040)<\#9>$(1,207,243)<\#9>$<\#9>2,152,344 Adjustments to reconcile income (loss) from continuing ooperations to <\#9>net cash provided from operating activities(loss) from continuing operations(1)(2)(5)<\#9>(901,040)<\#9>(1,207,243)<\#9>2,152,344<\#9>1,747,638<\#9>1,651,617<\#9>1,472,525<\#9>1,525,517<\#9>1,469,300<\#9>1,460,842<\#9>1,375,273 Diluted earnings (loss) per share from continuing operations(1)(2)(3)<\#9>(0.69)<\#9>(0.92)<\#9>1.61<\#9>1.33<\#9>1.28<\#9>1.18<\#9>1.24<\#9>11      3<\#9>/\&%H<\#9>  <\#175> U%<\#200>-N$ <\#132> <\#152> | aD <\#135> ~ g { p <\#132>D" d <\#211>D f <\#136> z"f?0?<\#183>?<\#130>?J99 compared <\#133>H<\#176><\#203><\#183><\#204><\#199><\#240><\#190><\#234><\#204><\#236><\#169><\#216><\#203><\#248><\#213><\#195><\#246><\#149>-    - "  <\#255><\#255><\#255>Fposal of agricultural products business <\#9><\#9>(including federal and foreign tax charges of $855,248)<\#9>(1,572,993)<\#9><\#9><\#209><\#9><\#209> Income (Loss) from Discontinued Operations<\#9>(1,469,647)<\#9>(19,878)<\#9>321,994 Net Income (Loss)<\#9><\#9>$<\#9>(2,370,,474,338 Basic Earnings (Loss) per ShareTen-Year Selected Financial Data (Dollar amounts in thousands except per share amounts)<\#202>6<\#201><\#201><\#201><\#201><\#201><\#201>7<\#200><\#200><\#200><\#200><\#200><\#200>8<\#199><\#199><\#199><\#199><\#199><\#199>9<\#198><\#198><\#198><\#198><\#198><\#198>:<\#197><\#197><\#197><\#197><\#197><\#197>;<\#196><\#196><\#196><\#196><\#196><\#196><<\#195><\#195><\#195><\#195><\#195><\#195>=<\#194><\#194><\#194><\#194><\#194><\#194>><\#193><\#193><\#193><\#193><\#193><\#193>?<\#192><\#192><\#192><\#192><\#192><\#192>@<\#191><\#191><\#191><\#191><\#191><\#191>A<\#190><\#190><\#190><\#190><\#190><\#190>B<\#189><\#189><\#189><\#189><\#189><\#189>C<\#188><\#188><\#188><\#188><\#188><\#188>D<\#187><\#187><\#187><\#187><\#187><\#187>E<\#186><\#186><\#186><\#186><\#186><\#186>F<\#185><\#185><\#185><\#185><\#185><\#185>G<\#184><\#184><\#184><\#184><\#184><\#184>H<\#183><\#183><\#183><\#183><\#183><\#183>I<\#182><\#182><\#182><\#182><\#182><\#182>J<\#181><\#181><\#181><\#181><\#181><\#181>5<\#221>5@****(8'ets<\#9>(159,430)<\#9>(205,739)<\#9>(445,380) <\#9>Depreciation<\#9>336,239<\#9>341,871<\#9>315,103 <\#9>Amortization<\#9>198,810<\#9>199,307<\#9>196,504 <\#9>Deferred income taxes<\#9>(797,510)<\#9>(6<\#247>6"4$)6fspcreco<\#154>posnTEXTAkzidenzGrotesk-BoldkindTEXTPS PairdfounTEXT Adobe Systems<\#189>versTEXT001.000kernlong<\#217>ofszlong<\#131>4pclstypefspcreco<\#156>posnTE<\#9>American Home Products Corporation and Subsidiariess``<\#255><\#255>stantially in 2000 and 1999 compared with prior years, and the ratio of current assets to current liabilities and average stockholders<\#213> equity has decreased substantially in 2000 and 1999 compared with prior years...&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>'  %    !<\#9>  W8.4(_!>D3-<\#177>Years Ended December 31,<\#9>2000<\#9>1999<\#9>1998 Net Revenue <\#9>$13,262,754<\#9>$11,881,196<\#9>$11,268,570 Cost of goods sold <\#9>3,269,418<\#9>3,022,556<\#9>2,843,185 Selling, general and administrative expenses <\#9>5,032,548<\#9>4,388,2265<\#9>4,209,162 Research and development expenses <\#9>1,68 /-34<\#129>;&4 ')'40$2Dc<\#162>1<:0E Wld <\#160> <\#152><<\#152> <\#255><\#225><\#224>"<\#128>M<\#179>M **(181<\#128>V<\#255><\#255><\#255>~S<\#187><\#204>S<\#190>`<\#253><\#250>@<\#153>R j Consolidated Balance Sheets (In thousands except share and per share amounts)<\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#188>~@<\#134>y<\#176> <\#232><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#188>]<\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#9>American Home Products Corporation and Subsidiaries<\#9>d or deconsolidated: <\#9><\#9>Accounts receivable <\#9>(433,182)<\#9>164,588<\#9>(391,921) <\#9><\#9>Inventories<\#9>31,188<\#9>(115,699)<\#9>(100,493) <\#9><\#9>Other current assets<\#9>179,817<\#9>(170,478)<\#9>(213,003) <\#9><\#9>Trade accounts payable and accrued expenses <\#9>270,518<\#9>(73,946)<\#9>(21,545) <\#9><\#9>Accrued Other iN<\#184>N **('8''AAmerican Home Products <\#213>00 Annual Report<\#202><\#202>10, 9, 8.5 Helvetica BQ Light Cond. w/Inserat; 22, 10/12, 8.5/10 ACaslon Reg. w/Italic & Bold <\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255>65<\#9>4,209,162 Research and development expenses <\#9>1,687,889<\#9>1,587,505<\#9>1,475,862 Interest expense, net <\#9>57,562<\#9>213,866<\#9>207,157 Other income, net <\#9>(161,039)<\#9>(255,697)<\#9>(285,848) Gains on sales of business and <\#9><\#9>(237,408)<\#9>(277,942) Gain on sales of business and Consolidated Statements of Operations (In thousands except per share amounts) amounts)<\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255>federal and foreign taxes<\#9>(393,330)<\#9>(121,227)<\#9>(4,008) <\#9>Other items, net<\#9>178,851<\#9>377,592<\#9>82,082 Net cash provided from continuing operations<\#9>477,342<\#9>2,493,377<\#9>1,350,751 Net cash provided from/(used for) dddating activities<\#9>554,942<\#9>2,155,423<\#9>1,360,825 Invest3     <\#9><\#9>L 0 ( <\#219><\#9>n * : <   <\#198>,863 Inventories<\#9><\#9>1,531,727<\#9>1,607,960 Net assets<\#209>discontinued business held for sale<\#9><\#9><\#209><\#9>4,192,346 Other current assets including deferred taxes <\#9><\#9>2,923,475<\#9>1,781,307 Total Current Assets <\#9><\#9>10,180,811<\#9>12,384,778 Property, plant and equipment: <\#9>Land<\#9><\#9>149,85<\#255>5)$"35 <\#132> { d x m <\#132><\#9>" d <\#211><\#9> f <\#136> z?k"9"<\#183>"<\#130>"Ivertible preferred stock, par value $2.50 pe<\#9>federal and foreign taxes <\#9>(1,101,040)<\#9>(1,907,299)<\#9>3,089,936 Provision (bene<\#222>t) for federal and foreign taxes<\#9>(200,000)<\#9>(700,056)<\#9>937,592 Income (Loss) from Continuing Operations<\#9>(901,040)<\#9>(1,207,243)<\#9>2,152,344 Discontinued operatiooios:<\#9>Income (loss) fare; 5,000,000 <\#9>shares authorized<\#9><\#9>55<\#9>61 Common stock, par value $0.331<\#218>3 per share; 2,400,000,000 shares authorized <\#9>(outstanding shares: 2000<\#209>1,311,774,000 and 1999<\#209>1,303,916,000)<\#9><\#9>437,258<\#9>434,639 Add1,774,000 and 1999<\#209>1,303,916,000)<\#9><\#9><\#9>434,639 Addtangibles, net of accumulated amortization <\#9>(2000<\#209>$1,739,368 and 1999<\#209>$1,667,711)<\#9><\#9>4,052,410<\#9>4,823,309 Other assets including deferred taxes<\#9><\#9>1,824,421<\#9>1,797,492 Total Assets<\#9><\#9>$21,092,466<\#9>$23,123,756 Liabilities Loans payable<\#9><\#9>$58,717<\#9>$<\#202>1,880,816 Trad10<\#9>135,013 <\#9>Buildings<\#9><\#9>2,694,612<\#9>2,598,890 <\#9>Machinery and equipment <\#9><\#9>3,510,529<\#9>3,269,793 <\#9>Construction in progress<\#9><\#9>1,223,282<\#9>389,252 <\#9><\#9><\#9><\#9>7,578,233<\#9>6,392,948 Less accumulated depreciation <\#9><\#9>2,543,409<\#9>2,274,771 <\#9><\#9><\#9><\#9>5,034,824<\#9>4,118,177 Goodwill and other inLiabilities Loans payable<\#9><\#9>$<\#202><\#202><\#202>58,717<\#9>$<\#202>1,880,816 Trade accounts payable <\#9><\#9>595,233<\#9>562,679 Accrued expenses <\#9><\#9>8,831,459<\#9>3,809,525 Accrued federal and foreign taxes <\#9><\#9>256,650<\#9>227,363 Total Current Liabilitiesreign taxes <\#9><\#9><\#9>227,363 Total Current Liabilities<\#9><\#9>h<\#211><\#148><\#216><\#128><\#209><\#210><\#132><\#224><\#135><\#212><\#208><\#134><\#220><\#235><\#129><\#238><\#129><\#240><\#196><\#180><\#248><\#174><\#136><\#189><  (< <\#197>k options<\#9><\#9>4,949<\#9>405,933<\#9><\#9><\#9>410,882 Conversion of preferred stock <\#9>and other exchanges<\#9>(6)<\#9>142<\#9>170,135<\#9>(6,663)<\#9><\#9>163,608 International operations year end change<\#9><\#9><\#9><\#9>53,171<\#9><\#9>53,171 Bpanying notes are an integral part of these Consolidated Financial Statement<\#9>&%2#4<\#9> ( <!,%<\#207>< > " W<\#216><\#9>(@1,2,L,A,.,1,L,!,*, (,oM;I,<\#245> <\#128>H<\#200>Immunex common stock<\#9>(2,061,204)<\#9><\#209><\#9>(592,084) Termination fee <\#9>(1,709,380)<\#9><\#209><\#9><\#209> Litigation charges <\#9>7,500,000<\#9>4,750,000<\#9><\#209> Goodwill impairment<\#9>401,000<\#9><\#209><\#9><\#209> Special charges <\#9>347,000<\#9>82,000<\#9>321,200 Income (loss) from continuing operations before before before 5;+ZP5@+\R5B*W$11,881,196<\#9>$11,268,570 Cost of goods sold <\#9>3,269,418<\#9>3,022,556<\#9>2,843,185 Selling, general and administrative expenses <\#9>5,032,548<\#9>4,388,265<\#9>4,209,162 Research and development expenses <\#9>1 <\#9><\#9>9,742,059<\#9>6,480,383 Long-term debt<\#9><\#9>2,394,790<\#9>3,606,423 Other noncurrent liabilities<\#9><\#9>5,226,495<\#9>5,925,313 Accrued postretirement bene<\#222>ts other than pensions<\#9><\#9>911,029<\#9>896,890 Stockholders<\#213> Equity $2.00 convertible preferred stock, par value $2.50 per shhitional paid-in capital <\#9><\#9>3,952,457<\#9>3,392,705 Retained earnings (accumulated de<\#222>cit)<\#9><\#9>(899,118)<\#9>3,000,827 Accumulated other comprehensive loss<\#9><\#9>(672,559)<\#9>(613,485) Total Stockhhings <\#9><\#9><\#9>3,000,827 Accumulated other comprehensive loss<\#9><\#9><\#9>(613,485) Total Stockh687)<\#9>$<\#9>(1,227,121)<\#9>$<\#202>2,474,338 Basic Earnings (Loss) per Share from Continuing Operations<\#9><\#9>$<\#9>(0.69)<\#9>$<\#9>(0.92)<\#9>$<\#202><\#202><\#202><\#202><\#202>1.64 Basic Earnings (Loss) per Share from Discontinued Operations<\#9>(1.12)<\#9>(0.02)<\#9>0.24 Basic Earnings (Loss) per Share <\#9><\#9>$<\#9>(1.81)<\#9>$<\#9>(0<\#9>(0<\#9>$<\#9>(0ns:<\#9>Income (loss) from operations of discontinued agricultural <\#9><\#9>products business (including federal and foreign taxes of <\#9><\#9>$57,289, $1,551 and $173,530 for 2000, 1999 and 1998, <\#9><\#9>respectively)<\#9>103,346<\#9>(19,878)<\#9>321,994 <\#9>Loss on disal products business66"4$)6le <\#9><\#9><\#9>757,815 Accrued expenses <\#9><\#9><\#9>4,212,554 Accrued federal and foreign taxes <\#9><\#9><\#9>227,363 Total CurCurrTotal Currtal Curr3 Total Currong-term debt<\#9><\#9><\#9>3,859,163 Other noncurrent liabilities<\#9><\#9><\#9>2,3olders<\#213> Equity<\#9><\#9>2,818,093<\#9>6,214,747 Total Liabilities and Stockholders<\#213> Equity <\#9><\#9>$21,092,466<\#9>$23,123,756 The accompanying notes are an integral part of these Consolidated Financial Statements. <\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215><\#203><\#218><\#215>2"6<\#9> (< (%3"(<<\#222>prehensive loss<\#9><\#9><\#9><\#9><\#9><\#9>(1,512,269) Cash dividends declared: <\#9>Preferred stock (per share: $2.00)<\#9><\#9><\#9><\#9>(50)<\#9><\#9>(50) <\#9>Common stock (per share: $0.905)<\#9><\#9><\#9><\#9>(1,183,571)<\#9><\#9>(1,183,571) Common stock acquired for treasury<\#9><\#9>(6,409)<\#9>(39,505)<\#9>(1,012,385)<\#9><\#9>(1,058,299) Common sNet income <\#9><\#9><\#9><\#9>2,474,338<\#9><\#9>2,474,338 Currency translation adjustments<\#9><\#9><\#9><\#9><\#9>(45,803)<\#9>(45,803) Unrealized loss on marketable securities<\#9><\#9><\#9><\#9><\#9>(2,428)<\#9>(2,428) <\#9>Comprehensive income<\#9><\#9><\#9><\#9><\#9><\#9>2,426,107 Cash dividends declared: <\#9>Preferred stock (per share: $2.00)<\#9><\#9><\#9><\#9>(54)<\#9><\#9>(54) <\#9>Common stock (per share: $0.87)<\#9><\#9><\#9><\#9>(1,143,198)<\#9><\#9>(1,143,198) Common stock acquired for treasury<\#9><\#9>(2,521)<\#9>(34,984)<\#9>(377,098)<\#9>098)<\#9><\#9>14,603) Common stock issued for stock options<\#9><\#9>4,342<\#9>399,488<\#9><\#9><\#9>403,830 Conversion of preferred stock<\#9>and other exchan<\#9><\#9>$2.00<\#9><\#9><\#9>Retained<\#9>Accumulated <\#9><\#9>Convertible<\#9><\#9>Additional<\#9>Earnings<\#9>Other<\#9>Total <\#9><\#9>Preferred<\#9>Common<\#9>Paid-in<\#9>(Accumulated<\#9>Comprehensive<\#9>Stockholders<\#213> <\#9><\#9><\#9>Earnings<\#9>Loss<\#9>Equity Balance at December 31, 1998<\#9>$72<\#9>$435,298<\#9>$2,530,696<\#9>$<\#9>5,489,292<\#9>$(280,106)<\#9>$<\#9>8,175,257,674<\#9>(10,551)<\#9><\#9>167,462 Balance at December 31, 1998<\#9>64<\#9>437,466<\#9>3,072,874<\#9>6,432,729<\#9>(328,337)<\#9>9,614,796 Net loss <\#9><\#9><\#9><\#9>(1,227,121)<\#9><\#9>(1,227,121) Currency translation adjustments<\#9><\#9><\#9><\#9><\#9>(285,963)<\#9>(285,963) Unrealized gain on marketable securities<\#9><\#9><\#9><\#9><\#9>815<\#9>815 <\#9>Com.94)<\#9>$<\#202><\#202><\#202><\#202><\#202>1.88 Diluted Earnings (Loss) per Share from Continuing Operations<\#9><\#9>$<\#9>(0.69)<\#9>$<\#9>(0.92)<\#9>$<\#202><\#202><\#202><\#202><\#202>1.61 Diluted Earnings (Loss) per Share from Discontinued Operations<\#9>(1.12)<\#9>(0.02)<\#9>0.24 Diluulu Share from discontinued operations<\#9>(1.12)<\#9>()<\#9>627,071 Diluom/(Used for) Investing Activities<\#9>4,485,651<\#9>(1,015,610)<\#9>1,203,136 Financing Activities Net proceeds from/(repayments of) debt<\#9>(3,080,381)<\#9>1,593,468<\#9>(1,174,137) Dividends paid<\#9>(1,201,477)<\#9>(1,183,621)<\#9>(103) Exercises of stock options<\#9>410,882<\#9>234,270<\#9>403,830,143,252) Purchases of common stock for treasury <\#9>(393,077)<\#9>(1,058,299)<\#9>(414,603) Exercises of stock options<\#9>410,882<\#9>234,270<\#9>403,830 Termination of interest rate swap agreements<\#9><\#209><\#9><\#209><\#9>(96,655) Net Cash Used for Financing Activities <\#9>(4,264,053)<\#9>(414,182)<\#9>(22Stock<\#9>Stock<\#9>Capital<\#9>Deficit)<\#9>Loss<\#9>Equity Balance at January 1, 1998<\#9>$72<\#9>$435,298<\#9>$2,530,696<\#9>$<\#9>5,489,292<\#9>$(280,106)<\#9>$<\#9>8,175,252 @<\#159>@<\#159>@ #}<\#255><\#255><\#227><\#215>"<\#170><\#224><\#9>D<\#128><\#159>@<\#128><\#159>@* -<\#168> <\#128>'<\#254><\#180>r"""<\#9><\#9>  <\#9> <\#9>    <\#219>d<\#242>d8**<\#9>*<\#9>('='A-1 col starts sect.<\#255><\#255><\#174><\#128><\#128>*<\#255><\#255><\#255><\#9>Q<\#194><\#136>Q<\#194><\#140>yJ@<\#153><\#183>k  <\#9>.<\#9># <\#9>,<\#9>9+<\#9>/* <\#226>$0.905)<\#9><\#9><\#9><\#9>(1,183,571)<\#9><\#9>(1,183,571) Common stock acquired for treasury<\#9><\#9>(6,409)<\#9>(39,505)<\#9>(1,012,385)<\#9><\#9>(1,058,299) Common stock issued for stock options<\#9><\#9>3,376<\#9>230,894<\#9><\#9><\#9>234,270 Conversion of preferred stock<\#9>and other exchanges<\#9>(3)<\#9>206<\#9>128,442<\#9>(8,775)<\#9><\#9>119Consolidated Statements of Cash Flows (In thousands)<\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255>WH&6/%DB+C7V9$7= %2=J?U P2&9 5 %2>N?TR2&7<\#223> ; %2=J?U;!X(W2=J?U PD&9 5 %2>N?TRD&7<\#9>(414,603) Common stock issued for stock options<\#9><\#9>4,342<\#9>399,488<\#9><\#9><\#9>403,830 Conversion of preferred stock<\#9>and other exchanges<\#9>(8)<\#9>347<\#9>17<\#128><\#202><\#128><\#193><\#128><\#205><\#128>+ @<\#171>~<\#250>'<\#254><\#180>r"""<\#128>r"""<\#206>@<\#205>@<\#207><\#191><\#255>+ @<\#255><\#255><\#227><\#215>!<\#191><\#224>:<\#160><\#255><\#128>@,084) <\#9>Goodwill impairment <\#9>401,000<\#9><\#209><\#9><\#209> <\#9>Special charges<\#9>347,000<\#9>82,000<\#9>321,200 <\#9>Gains on sales of assets<\#9>(159,430)<\#9>(205,739)<\#9>(445,380) <\#9>Depreciation<\#9>336,239<\#9>341,871<\#9>315,103 <\#9>Amortization<\#9>198,810<\#9>199,307<\#9>196,504 <\#9>Deferred income taxes<\#9>(814,282)<\#9>(1,411(1,41* !  * <\#9>" ;<\#9>  /<\#255><\#255><\#255>0,068)<\#9>51,952 <\#9>Diet drug litigation payments<\#9>(3,966,845)<\#9>(117,581)<\#9><\#209> <\#9>Deconsolidation of Immunex<\#9>(236,768)<\#9><\#209><\#9><\#209> <\#9>Changes in working capital, net of businesses acquired, <\#9><\#9>sols in working capital, net of businesses acquired, <\#9><\#9>soll<\#9>solololsolquired, <\#9><\#9>sol.  ' <\#9>, ' * &<\#9>&,  , Wp(/:O=<\#141>)*)M)")()8)&)&)4)7)*U)3)))3)I)@<\#231><\#9>American Home Products Corporation and Subsidiariesft-curren <\#235>g@<\#208> <\#254><\#128><\#128><\#150><\#224><\#255><\#255><\#255><\#255><\#255><\#255> <\#235>g<\#128><\#255><\#207>+<\#244> <\#235>g<\#176><\#171>p<\#137><\#128><\#150><\#225><\#141><\#255><\#250> <\#150><\#134><\#243><\#220><\#215><\#133> <\#141><\#255><\#250> <\#150><\#134><\#243><\#220><\#215><\#133><\#150><\#134><\#243> <\#141><\#255><\#250> <\#141><\#255><\#250><\#220><\#215><\#133><\#150><\#134><\#243><\#220><\#215><\#133><\#150><\#134><\#243> 3'ACa <\#235>f<\#224> <\#235>g<\#176>0 <\#254><\#128><\#128><\#146><\#224><\#141><\#255><\#250> <\#235>g<\#176>)I$R1H0<K)9)8)9)6)AAT>W0<I)3)H)3A:'J'E#?ALL*W<\#153><\#156> iscontinued operations<\#9>77,600<\#9>(327,771)<\#9>10,074 Net Cash Provided from Operating Activities<\#9>554,942<\#9>2,165,606<\#9>1,360,825 Investinnn*~<\#255><\#255><\#255><\#207>+<\#244> Black&<\#171>,?<\#128> <\#239>D&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@*~Z<\#228>0v<\#220>ZD&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>g Activities Purchases of property, plant and equipment<\#9>(1,681,906)<\#9>(937,435)<\#9>(690,058) Purchase of business, net of cash acquired<\#9><\#209><\#9><\#209><\#9>(425,041) Proceeds from sales of businesses<\#9>3,800,000<\#9><\#209><\#9>1,770,000 Proceeds from sale of Immunex common stock<\#9>2,404,875555 $<\#138>,<\#255><\#255><\#255><\#128>H<\#128>$<\#128><\#128> $3<\#152> $<\#137><\#228><\#255><\#255><\#255><\#128>H<\#128>$<\#128><\#128> OP<\#132>$<\#136>3 (w<\#148><\#255><\#255><\#255>$<\#128>$<\#128>0<\#128>0<\#128> $3<\#152> <\#239>,870 Balance at December 31, 1999<\#9>61<\#9>434,639<\#9>3,392,705<\#9><\#9>3,000,827<\#9>(613,485)<\#9><\#9>6,214,747 Net loss <\#9><\#9><\#9><\#9>(2,370,687)<\#9><\#9>(2,370,687) Currency translation adjustments<\#9><\#9><\#9><\#9><\#9>(70,496)<\#9>(70,496) Unrealized gain on marketable securities<\#9><\#9><\#9><\#9><\#9>11,422<\#9>11,422 <\#9>Comprehensive loperations to <\#9>net cash provided from operating activities of continuing operations: <\#9>Litigation charges<\#9>7,500,000<\#9>4,750,000<\#9><\#209> <\#9>Gains on sales of business and Immunex common stock<\#9>(2,061,204)<\#9><\#209><\#9>(5922<\#9>401,000<\#9><\#209><\#9><\#209> <\#9>Gains on sales of assets<\#9>(159,430)<\#9>(205,739<\#9><\#209><\#9><\#209> Proceeds from sales of assets<\#9>256,192<\#9>327,730<\#9>620,632 Purchases of marketable securities<\#9>(677,802)<\#9>(789,846)<\#9>(350,687) Proceeds from sales and maturities of marketable securities<\#9>384,292<\#9>383,941<\#9>278,290 Net Cash Provided fred frres<\#9>4,485,651<\#9>(1,055,42ency translation adjustments<\#9><\#9><\#9><\#9><\#9>(70,496)<\#9>(70,496) Unrealized gain on marketable securities<\#9><\#9><\#9><\#9><\#9>11,422<\#9>11,422 <\#9>Comprehensive loss*~<\#255><\#255><\#255><\#207>+<\#244> Black&<\#171>,?<\#128> <\#239>D&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@*~Z<\#228>0v<\#220>ZD&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>$<\#137>P<\#255><\#255><\#255>$<\#128>$<\#128>0<\#128>0<\#128> <\#181> R <\#181> A-1 col starts sect.<\#255><\#255><\#239><\#169><\#128><\#128>i<\#255><\#255><\#241>p $<\#137><\#144> $<\#139><\#192><\#241><\#251>@<\#241><\#9><\#9><\#9><\#9><\#9><\#9>(2,429,761) Cash dividends declared: <\#9>Preferred stock (per share: $2.00)<\#9><\#9><\#9><\#9>(46)<\#9><\#9>(46) <\#9>Common stock (per share: $0.92)<\#9><\#9><\#9><\#9>(1,201,431)<\#9><\#9>(1,201,431) Common stock acquired for treasury<\#9><\#9>(2,472)<\#9>(16,316)<\#9>(374,289)<\#9><\#9>(393,077) Common stock issued for stoc<\#153><\#183><\#255>q <\#133><\#255>q <\#128><\#128>j<\#255><\#255><\#138><\#169> ) <\#240> $<\#144><\#160><\#175>0@<\#153><\#156><\#243><\#202>Consolidated Statements of Changes in Stockholders<\#213> Equity (In thousands except per share amounts))<\#244><\#241><\#218><\#244><\#241><\#218><\#244><\#241><\#218><\#244><\#241><\#218><\#244><\#241><\#218><\#244><\#240><\#218><\#244><\#240><\#218><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#217><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#244><\#240><\#216><\#243><\#240><\#216><\#243><\#240><\#216><\#243><\#240><\#215><\#243><\#240><\#215><\#243><\#240><\#215><\#243><\#240><\#215><\#243><\#239><\#215><\#243><\#239><\#215><\#243><\#239><\#215><\#243><\#239><\#215> j <\#128><\#128><\#255><\#255><\#241>E $<\#138><\#236> (<\#251><\#240>-@@<\#153>H4<\#146>v<\#245>,424,817) Effects of exchange rates on cash balances<\#9>(24,949)<\#9>(25,418)<\#9>(8,197) Increase in Cash and Cash Equivalents <\#9>751,591<\#9>710,396<\#9>11nts <\#9>751,591<\#9>710,396<\#9>1n cash balances<\#9>(24,949)<\#9>(25,418)<\#9>(8,197) Increase in cash and cash equivalents <\#9>751,591<\#9>710,396<\#9>1  <\#128><\#128><\#255><\#255><\#254>( )0 4<\#160>G-@<\#153><\#175>4<\#253>v<\#252>ted Earnings (Loss) per Share <\#9><\#9>$<\#9>(1.81)<\#9>$<\#9>(0.94)<\#9>$<\#202><\#202><\#202><\#202><\#202>1.85 The accompanying notes are an integral part of these Consolidated Financial Statements.<\#9>(0.94)<\#9>$<\#202><\#202><\#202><\#202><\#202>1.85 The accompanying notes are an integral part of these Consolidated Financial Statements.<\#9>American Home Products Corporation and Subsidiaries<\#9><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255>alance at December 31, 2000<\#9>$55<\#9>$437,258<\#9>$3,952,457<\#9>$<\#9>(899,118)<\#9>$(672,559)<\#9>$<\#9>2,818,093 The accompanying notes are an integral part of these Consolidated Financial Statements..<\#128> <\#239>D&<\#170>p]b<\#192>u<\#156>h<\#255><\#247>@*~Z<\#228>0v<\#220>ZD&<\#170><\#144>DH<\#200> <\#128><\#255><\#254><\#128>30,947 Cash and Cash Equivalents, Beginning of Year<\#9>1,892,715<\#9>1,182,319<\#9>1,051,372 Cash and Cash Equivalents, End of Year<\#9>$<\#9>2,644,306<\#9>$<\#9>1,892,715<\#9>$<\#9>1,182,319 The accompanying notes are an integral part of these Consolidated Financial Statements..<\#159><\#205><\#178><\#159><\#205><\#178><\#159>55)$"35<\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255>66"4$)6<\#9> |<\#213>erican Home Products <\#213>99 Annual Report<\#202><\#202>10, 9 Akzidenz Grotesk Bold22/24, 10/12, 9/11 Bodoni MT Book w/Book Italic & BoldItalic & BoldHr  <\#128><\#128><\#9><\#255><\#255><\#255><\#196> &<\#152>H &<\#152>$$<\#193>@<\#153>H<\#172><\#146><\#238><\#253>  <\#128><\#128><\#255><\#255><\#255><\#248> &<\#159><\#248> &<\#151><\#192><\#253>@<\#153><\#175><\#172><\#253><\#238><\#254>  <\#128>k<\#255><\#255><\#255><\#247> $<\#138><<\#247><\#242>@<\#153>><\#9>American Home Products Corporation and Subsidiaries <\#201><\#176><\#204> <\#201><\#176><\#204>`<\#173><\#210>7<\#197>`<\#173><\#210>7<\#197> <\#138><\#231><\#137>5<\#240>.y<\#248><\#229><\#240>.<\#231><\#137>5<\#231><\#137>5y<\#248><\#229><\#240>.y<\#248><\#229><\#240>.<\#138>a<\#158> <\#232><\#151>y<\#248><\#229> <\#232><\#151>a<\#158>a<\#158>y<\#248><\#229> <\#232><\#151>y<\#248><\#229> <\#232><\#151><\#138>#: +<\#193>t<\#255><\#139>+<\#193> #: #:t<\#255><\#139>+<\#193><\#128>l<\#255><\#255><\#255><\#246> 3<\#252><\#246><\#243>@<\#153><\#255><\#255>=<\#255><\#255><\#163><\#132>$<\#136>3 )'<\#208>$<\#128>$<\#128>0<\#128>0<\#128> $3<\#152> ))<\#216><\#255>$<\#128>$<\#128>0<\#128>0<\#128> .<\#253><\#238><\#171><\#213><\#181> ]<\#181> =<\#255><\#255><\#255><\#253><\#128><\#128>n<\#255><\#255><\#255>c ({$ )*<\#172><\#246><\#251>@<\#153><\#183><\#255>q <\#133><\#255>q <\#128><\#128>u<\#255><\#255><\#255>r (v<\#176> $<\#139><\#152><\#254><\#250>@<\#153>H<\#172><\#146><\#238> <\#128><\#128>w<\#255><\#255><\#255><\#139> .<\#148> -<\#148><\#253><\#250>@<\#153><\#174><\#255><\#188><\#184><\#254><\#208>v   <\#128><\#168><\#255><\#255><\#255><\#254><\#255><\#166> $<\#140><\#204><\#254><\#252>I<\#128>@<\#153><\#172><\#128><\#135><\#128><\#172><\#128><\#168><\#128><\#128><\#128><\#255><\#255><\#255><\#255> (wX $<\#139>T<\#254><\#250>@<\#153>H4<\#146>v  <\#128><\#128>v<\#255><\#255><\#255>S (v, ) 0<\#253><\#250>@<\#153><\#156> j @<\#128>|<\#255><\#255><\#255><\#254> &<\#152><\#208><\#254><\#251>@<\#153>><\#128><\#132><\#255><\#255><\#255><\#253> $<\#138> <\#253><\#248>@<\#153><\#255><\#255>=<\#255><\#255><\#163><\#132>$<\#136>3 &<\#151>t <\#255>$<\#128>$<\#128>0<\#128>0<\#128> $3<\#152> $<\#139><!<\#255>$<\#128>$<\#128>0<\#128>0<\#128> L<\#141><\#164><<\#215>1<\#128>R <\#181><\#9> <\#255><\#255><\#255><\#246><\#128><\#128>p<\#255><\#255><\#255>B (w<\#176> $<\#139><\#255><\#250>@<\#153><\#183><\#255>q <\#133><\#255>q  <\#128><\#128>x<\#255><\#255><\#255>2 )"@ &<\#170><\#232><\#253><\#250>@<\#153><\#156> j  <\#128><\#128><\#255><\#255><\#255>I &<\#152><\#172> (vt<\#253><\#250>@<\#153>H4<\#146>v <\#128><\#128><\#255><\#255><\#255>W ZP )@<\#253><\#250>@<\#153><\#175>?<\#253><\#189><\#253>u<\#252><\#195>  <\#128><\#128><\#238><\#255><\#255><\#255>M &<\#167><\#152> &<\#164><\#192> <\#253><\#250>@<\#153>H<\#172><\#146><\#238>  <\#128><\#171><\#255><\#255><\#255><\#254><\#255><\#166> &<\#159><\#244><\#254><\#252>I<\#128>@<\#153><\#172><\#128><\#192><\#172><\#128>#<\#192><\#128><\#128><\#240><\#255><\#255><\#255>g 5< &<\#152><\#212><\#254><\#250>@<\#153><\#175><\#184> nw<\#238>   <\#128><\#169><\#255><\#255><\#255><\#254><\#255><\#166> )8<\#254><\#252>I<\#128>@<\#153><\#172><\#128><\#212><\#192><\#172><\#128><\#245><\#192><\#128>~<\#255><\#255><\#255><\#253> &<\#160><\#200><\#253><\#248>@<\#153>><\#128><\#134><\#255><\#255><\#255><\#252> &<\#152><\#128><\#252><\#249>@<\#153><\#255><\#255>=<\#255><\#255><\#163><\#132>$<\#136>3 ({<"<\#255>$<\#128>$<\#128>0<\#128>0<\#128> $3<\#152> )$<\#224>#<\#255>$<\#128>$<\#128>0<\#128>0<\#128> Xr<\#152><\#205>g<\#167><\#128><z<\#160><\#218>3<\#181> <\#255><\#255><\#255><\#241><\#128><\#128>-<\#255><\#255><\#255>< (| ) <\#208><\#248><\#250>@<\#153><\#175><\#184>|Z<\#237><\#254><\#180>  <\#128><\#176><\#255><\#255><\#255><\#254> (|X<\#254><\#251>@<\#153>G<\#192>c~<\#177><\#248><\#160><\#225><\#255><\#152><\#128><\#128>r<\#255><\#255><\#255> )%<\#252> )!<\#148><\#254><\#250>@<\#153><\#183><\#255>q <\#133><\#255>q <\#128><\#128>z<\#255><\#255><\#255> A<\#128> &<\#169><\#156><\#253><\#250>@<\#153><\#156> j <\#128><\#128>U<\#255><\#255><\#255>T $w<\#172> 3|<\#253><\#250>@<\#153>H4<\#146>v <\#128><\#128>W<\#255><\#255><\#255>m $<\#146><\#140> $<\#145><\#176><\#253><\#250>@<\#9>American Home Products Corporation and Subsidiaries<\#9><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#153><\#175>@<\#217>v   <\#128><\#175><\#255><\#255><\#255><\#254><\#255><\#166> 8<<\#254><\#252>I<\#128>@<\#153><\#172><\#128><\#192><\#172><\#128>#<\#192><\#128><\#128>+<\#255><\#255><\#255>% )&h $wD<\#254><\#250>@<\#153>H<\#172><\#146><\#238> <\#128><\#128><\#255><\#255><\#255><\#254> )8<\#254><\#251>@<\#153>><\#128><\#136><\#255><\#255><\#255><\#253> ({0<\#253><\#248>@<\#153><\#255><\#255>=<\#255><\#255><\#163><\#218><\#158><\#179><\#193><\#193><\#193><\#193><\#193><\#193><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218><\#218>AkzidenzGrotesk-Bold BodoniMT-BookHelvetica-Condensed-BoldH<\#187>j>43ba<\#135>G.<\#242> )$D $<\#145><\#228> &<\#160>4jYAT<\#255>AV<\#255>pAW<\#255>pAY<\#255>Av<\#255><\#174>Aw<\#255><\#174>Ay<\#255><\#174>A<\#213><\#255>F,<\#254>=F.<\#254>=FA<\#255>pLT<\#254><\#204>LV<\#254><\#204>LW<\#254><\#204>LY<\#254><\#143>Ly<\#255>pL<\#213><\#254><\#143>P,<\#253><\#235>P.<\#253><\#235>PA<\#255>p<\#255><\#255><\#254><\#225><\#9>American Home Products Corporation and Subsidiaries \<\#152> <\#235>j<\#128><\#171>0<\#137>L<\#128><\#160><\#141><\#255><\#250>gq<\#210>t<\#255><\#139>4p<\#172><\#232>$`<\#156><\#216><\#138><\#141><\#255><\#250> <\#150><\#134><\#243><\#220><\#215><\#133><\#150><\#134><\#243> <\#141><\#255><\#250> <\#141><\#255><\#250><\#220><\#215><\#133><\#150><\#134><\#243><\#220><\#215><\#133><\#150><\#134><\#243> <\#138><\#171><\#216>c <\#180>_\<\#220><\#215><\#133><\#180>_\ <\#171><\#216>c <\#171><\#216>c<\#220><\#215><\#133><\#180>_\<\#220><\#215><\#133><\#180>_\ <\#138><\#9>American Home Products Corporation and Subsidiaries<\#9><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255><\#255>RT<\#255><\#174>RY<\#255><\#174>T,<\#254><\#143>T-<\#255>T.<\#254><\#143>T:<\#254><\#204>T;<\#254><\#204>TA<\#255>Ta<\#254><\#204>Tc<\#254><\#204>Te<\#254><\#204>Ti<\#255><\#174>To<\#254><\#204>Tr<\#254><\#204>Ts<\#254><\#204>Tu<\#254><\#204>Tw<\#254><\#204>Ty<\#255>V,<\#254><\#143>V-<\#255><\#174>V.<\#254><\#143>V:<\#255><\#174>V;<\#255><\#174>VA<\#255>pVa<\#255><\#174>Ve<\#255><\#174>Vo<\#255><\#174>Vr<\#255><\#174>Vu<\#255><\#174>W,<\#254><\#204>W-<\#255><\#174>W.<\#254><\#204>WA<\#255><\#174>Wa<\#255><\#174>We<\#255><\#174>Wo<\#255><\#174>Y,<\#254>=Y-<\#254><\#204>Y.<\#254>=Y:<\#255>pY;<\#255>pYA<\#255>Ya<\#255>Ye<\#255>Yi<\#255><\#174>Yo<\#255>Yp<\#255>pYq<\#255>Yu<\#255>pYv<\#255><\#174>f<\#213>Qr,<\#254><\#204>r-<\#255>pr.<\#254><\#204>rvQrwQrxQryQrzQtrfv,<\#255>v.<\#255>w,<\#255>pw.<\#255>py,<\#255>y.<\#255><\#212><\#212><\#255><\#174><\#213>s<\#255><\#213><\#213><\#255><\#174><\#142><\#226>(J<\#255>;(f<\#255><\#157>(g<\#255><\#157>(j<\#255>(y<\#255><\#197>AC<\#255>AG<\#255>(AO<\#255>AQ<\#255>AT<\#254><\#158>AU<\#254><\#198>AV<\#253>dAW<\#254>)AY<\#253><\#199>Ap<\#255><\#157>Au<\#255>cAv<\#254><\#158>Aw<\#254><\#198>Ay<\#254><\#198>A<\#211><\#253><\#140>A<\#213><\#253><\#159>B,<\#255>cB.<\#255>;BA<\#255><\#157>BU'B<\#128><\#255><\#157>B<\#129><\#255><\#157>B<\#134>'C,<\#255><\#197>C.<\#255><\#157>CC<\#255><\#157>CO<\#255><\#197>D,<\#254><\#158>D.<\#254>dDA<\#254><\#198>DV<\#255>DW<\#255>;DY<\#254><\#158>D<\#128><\#254><\#198>D<\#129><\#254><\#198>F,<\#254>)F.<\#254>FA<\#254>dFa<\#255>cFe<\#255>Fi<\#255><\#157>Fl<\#255><\#197>Fo<\#255>Fr<\#255>(F<\#128><\#254>dF<\#129><\#254>dF<\#138>'F<\#140><\#255>cF<\#154><\#255>cG,<\#254><\#198><\#255><\#255><\#254><\#223>G.<\#254><\#158>GA<\#254><\#198>GG<\#255><\#197>GO<\#255><\#157>J,<\#254><\#198>J.<\#254><\#158>JA<\#255>Ja<\#255><\#197>Je<\#255><\#157>Jo<\#255>cJu<\#255>cJy<\#255>;J<\#128><\#255>J<\#129><\#255>J<\#138><\#255><\#197>J<\#140><\#255><\#197>J<\#154><\#255>cJ<\#159><\#255>cK)<\#255>;KC<\#254>dKG<\#254><\#158>KO<\#254><\#158>Ke<\#255>Ko<\#255>Ku<\#254><\#198>Kv<\#253><\#199>Kw<\#254>Ky<\#254>dK<\#133><\#254><\#158>K<\#154><\#255>K<\#159><\#254><\#198>LA<\#255><\#157>LC<\#255><\#157>LG<\#255><\#197>LO<\#255><\#197>LS'LT<\#254><\#158>LU<\#255><\#157>LV<\#254>)LW<\#254><\#158>LY<\#254>Lw<\#255>Ly<\#255><\#157>L<\#133><\#255><\#197>L<\#134><\#255><\#157>L<\#211><\#254><\#198>L<\#213><\#254><\#198>N,<\#255>;N.<\#254><\#198>NA<\#255>N<\#128><\#255>N<\#129><\#255>O,<\#254><\#158>O.<\#254>dOA<\#254><\#158>ON<\#255><\#157>OT<\#255><\#157>OV<\#255>OW<\#255>;OX<\#254><\#198>OY<\#254><\#198>O<\#128><\#254><\#158>O<\#129><\#254><\#158>P,<\#253>*P.<\#253>PA<\#253><\#199>Pa<\#255>Pe<\#254>dPo<\#254>dP<\#128><\#253><\#199>P<\#129><\#253><\#199>P<\#140><\#255>Q)<\#255><\#157>Q,<\#254><\#158>Q.<\#254>dQA<\#254><\#158>QT<\#255><\#157>QV<\#254><\#198>QW<\#255>;QY<\#254><\#198>Qf<\#255><\#157>Qg<\#255><\#157>Qp<\#255><\#197>Qy<\#255><\#197>R)<\#255>cRC<\#255>(RG<\#255>cRO<\#255>cRQ<\#255>cRT<\#255>RU<\#255>RV<\#254>)RW<\#254><\#158>RY<\#254><\#158>Re<\#255>cRo<\#255>cRu<\#255>;Rv<\#254><\#158>Rw<\#254><\#198>Ry<\#255>;R<\#133><\#255>cR<\#134><\#255>R<\#154><\#255>cR<\#159><\#255>;S,<\#255><\#197>S.<\#255><\#157>T,<\#254>dT-<\#255>;T.<\#254>)T:<\#255><\#197>T;<\#255><\#197>TA<\#254><\#198>TC<\#255><\#157>TG<\#255><\#197>TO<\#255><\#197>TQ<\#255><\#197>Ta<\#255>cTc<\#254><\#198>Te<\#254><\#198>Ti<\#255><\#197>Tm<\#254><\#158>To<\#254><\#198>Tr<\#255>;Ts<\#255>Tu<\#254><\#158>Tw<\#254><\#158>Ty<\#254>dTz<\#255>T<\#128><\#254><\#198>T<\#129><\#254><\#198>T<\#133><\#255><\#197>T<\#140><\#255>cU,<\#254><\#158>U.<\#254>dUA<\#254>dU<\#128><\#254>dU<\#129><\#254>dV,<\#254>)V-<\#254><\#198>V.<\#254>V:<\#255>V;<\#255>VA<\#253>dVC<\#255>VG<\#255>;VO<\#255>(VQ<\#255>;Va<\#254>dVe<\#254>)Vi<\#255>;Vo<\#254>)Vr<\#254>dVu<\#254>)Vy<\#254>dV<\#128><\#253>dV<\#129><\#253>dV<\#133><\#255>(V<\#140><\#254>dW,<\#253><\#199>W-<\#254><\#198>W.<\#253><\#159>W:<\#255>W;<\#255>WA<\#253><\#199>WC<\#254><\#198>WG<\#255>WO<\#255>Wa<\#254>)Wd<\#253><\#199>We<\#254>Wh<\#255><\#197>Wi<\#255>Wo<\#254>Wr<\#254>Wu<\#254>Wy<\#254>W<\#128><\#253><\#199>W<\#129><\#253><\#199>W<\#133><\#255>W<\#140><\#254>)XC<\#254><\#198>XG<\#255>XO<\#255>X<\#133><\#255>Y,<\#254>)Y-<\#254><\#198>Y.<\#254>Y:<\#255>;Y;<\#255>;YA<\#253>dYC<\#254><\#198>YG<\#255>YO<\#255>YS<\#255><\#197>Ya<\#254>)Yd<\#253><\#159>Ye<\#253><\#199>Yi<\#254><\#198>Yo<\#253><\#199>Yp<\#253><\#199>Yq<\#253><\#159>Yu<\#253><\#199>Yv<\#253><\#159>Y<\#128><\#253>dY<\#129><\#253>dY<\#133><\#255>Y<\#140><\#254>)ab<\#255><\#197>av<\#255>(aw<\#255>cay<\#255>cb,<\#255>(b.<\#255>bb<\#255><\#157>bl<\#255><\#157>bv<\#255>cbw<\#255><\#157>by<\#255>cc,<\#255>cc.<\#255>;ch<\#255><\#197>ck<\#255><\#197>cy<\#255><\#157>dd<\#255><\#157>dv<\#255>;dw<\#255>cdy<\#255><\#157>d<\#213>'e,<\#255><\#197>e.<\#255><\#157>eb<\#255><\#197>ev<\#255><\#157>ew<\#255><\#197>ey<\#255><\#197>ezbe<\#213><\#156>f f!&f)&f,<\#255><\#197>f.<\#255><\#157>f?<\#156>fe<\#255><\#157>ff<\#255><\#157>fk<\#255>cfl<\#255>cfo<\#255><\#157>fu<\#255><\#157>f<\#138>&f<\#140>'f<\#145><\#156>f<\#149><\#254>f<\#154>bf<\#159>'f<\#211><\#156>f<\#213><\#156>f<\#245><\#255><\#157>g,<\#255>cg.<\#255>;ga<\#255><\#197>ge<\#255><\#157>gg<\#255><\#157>gl<\#255><\#157>go<\#255><\#157>g<\#138><\#255><\#197>g<\#140><\#255><\#197>g<\#154><\#255><\#157>hy<\#255><\#157>iv<\#255><\#157>kc<\#255><\#157>kd<\#255>cke<\#255>ckg<\#255><\#157>kl<\#255><\#197>ko<\#255>ckp<\#255><\#157>kq<\#255>cks<\#255><\#197>ku<\#255><\#157>ky<\#255><\#157>k<\#154><\#255>ck<\#159><\#255><\#157>lw<\#255><\#157>ly<\#255><\#197>my<\#255><\#197>nv<\#255>cnw<\#255><\#157>ny<\#255><\#157>nz'n<\#213>'o,<\#255>(o.<\#255>og<\#255><\#197>ov<\#255>cow<\#255><\#157>ox<\#255><\#157>oy<\#255><\#157>p,<\#254><\#198>p.<\#254><\#158>pp<\#255><\#157>pw<\#255>;py<\#255><\#157>r,<\#254><\#158>r-<\#255><\#157>r.<\#254>dra'rd<\#255><\#197>rj<\#255><\#197>rk<\#255><\#197>rl<\#255><\#197>rm'rn'ro<\#255><\#197>rp'rq<\#255><\#197>rs'rt'rv<\#255><\#197>r<\#138>'r<\#140>'r<\#154><\#255><\#197>s,<\#255>cs.<\#255>;sw<\#255><\#157>v,<\#254><\#158>v.<\#254>dva<\#255><\#157>vc<\#255>cvd<\#255>;ve<\#255>cvo<\#255>cvq<\#255>;v<\#138><\#255><\#157>v<\#140><\#255><\#157>v<\#154><\#255>cw,<\#254><\#158>w.<\#254>dwa<\#255><\#197>wc<\#255><\#157>wd<\#255>cwe<\#255><\#157>wh<\#255><\#157>wo<\#255><\#157>wq<\#255>;w<\#138><\#255><\#197>w<\#140><\#255><\#197>w<\#154><\#255><\#157>xc<\#255><\#197>xd<\#255><\#157>xe<\#255><\#197>xo<\#255><\#197>x<\#154><\#255><\#197>y,<\#254><\#158>y.<\#254>dya<\#255><\#157>yc<\#255>cyd<\#255>;ye<\#255>cyg<\#255>cyo<\#255>cy<\#138><\#255><\#157>y<\#140><\#255><\#157>y<\#154><\#255>cy<\#213>'zc<\#156>zdbze<\#156>zobzpbz<\#154>b<\#128>C<\#255><\#128>G<\#255>(<\#128>O<\#255><\#128>Q<\#255><\#128>T<\#254><\#158><\#128>U<\#254><\#198><\#128>V<\#253>d<\#128>W<\#254>)<\#128>Y<\#253><\#199><\#128>u<\#255>c<\#128>v<\#254><\#158><\#128>w<\#254><\#198><\#128>y<\#254><\#198><\#128><\#211><\#253><\#140><\#128><\#213><\#253><\#159><\#129>C<\#255><\#129>G<\#255>(<\#129>O<\#255><\#129>Q<\#255><\#129>T<\#254><\#158><\#129>U<\#254><\#198><\#129>V<\#253>d<\#129>W<\#254>)<\#129>Y<\#253><\#199><\#129>v<\#254><\#158><\#129>w<\#254><\#198><\#129>y<\#254><\#198><\#129><\#211><\#253><\#140><\#129><\#213><\#253><\#159><\#133>A<\#254><\#158><\#133>T<\#255><\#157><\#133>V<\#255><\#133>W<\#255>;<\#133>X<\#254><\#198><\#133>Y<\#254><\#198><\#134>A<\#254>d<\#138>v<\#255>(<\#138>w<\#255>c<\#138>y<\#255>c<\#140>v<\#255>(<\#140>w<\#255>c<\#140>y<\#255>c<\#154>v<\#255>c<\#154>w<\#255><\#157><\#154>x<\#255><\#157><\#154>y<\#255><\#157><\#210>A<\#254><\#210><\#128><\#254><\#210><\#129><\#254><\#212>A<\#254><\#212><\#128><\#254><\#212><\#129><\#254><\#213>d<\#255>c<\#213>r<\#255><\#197><\#213>s<\#255>c<\#213>v<\#255><\#197><\#226><\#226><\#255>;<\#218>u19<\#254><\#170>97<\#255><\#142>AT<\#255>AV<\#255>`AW<\#255><\#187>AY<\#254><\#216>Av<\#255><\#187>Aw<\#255><\#187>Ay<\#255><\#187>A<\#213><\#254>|F,<\#253><\#244>F.<\#253><\#244>FA<\#255>`LT<\#254><\#216>LV<\#255>LW<\#255>LY<\#254>|<\#255><\#255><\#254><\#216>Ly<\#255>`L<\#213><\#253><\#244>P,<\#253><\#153>P.<\#253><\#153>PA<\#255>RTRVRWRY<\#255><\#187>RyT,<\#254>|T-<\#254><\#216>T.<\#254>|T:<\#254><\#216>T;<\#254><\#216>TA<\#255>Ta<\#254><\#216>Tc<\#254><\#216>Te<\#254><\#216>Ti<\#255>`To<\#254><\#216>Tr<\#255>Ts<\#254><\#216>Tu<\#255>Tw<\#254><\#216>Ty<\#254><\#216>V,<\#254>|V-<\#255>V.<\#254>|V:<\#255><\#187>V;<\#255><\#187>VA<\#255>`Va<\#255>`Ve<\#255>`Vi<\#255><\#187>Vo<\#255>`Vr<\#255><\#187>Vu<\#255><\#187>Vy<\#255><\#187>W,<\#255>W-<\#255><\#187>W.<\#255>W:<\#255><\#187>W;<\#255><\#187>WA<\#255><\#187>Wa<\#255><\#187>We<\#255><\#187>WiWo<\#255><\#187>WrWuWyY,<\#253><\#244>Y-<\#254>|Y.<\#253><\#244>Y:<\#254><\#216>Y;<\#254><\#216>YA<\#254><\#216>Ya<\#254>|Ye<\#254>|Yi<\#255>`Yo<\#254>|Yp<\#255>Yq<\#254>|Yu<\#255>Yv<\#255>fff<\#213>r,<\#254><\#216>r-<\#255>`r.<\#254><\#216>rcrdrerfrgrhrmrnrorqrrrtrurvrwrxryrzr<\#213>v,<\#255>v.<\#255>w,<\#255>w.<\#255>y,<\#255>y.<\#255><\#212><\#212><\#254>O<\#213>s<\#255><\#213>t<\#255><\#187><\#213><\#213><\#254>Ox )#<\#164><\#255><\#255><\#254><\#214>t<\#192><\#172><\#128>#<\#192><\#128><\#128><\#143><\#255><\#255><\#255> F<\#210><\#224> F<\#207><\#168> F<\#207><\#172><\#254><\#250>@